84 related articles for article (PubMed ID: 23583134)
1. Non-promoter DNA hypermethylation of Zygote Arrest 1 (ZAR1) in neuroblastomas.
Sugito K; Kawashima H; Yoshizawa S; Uekusa S; Hoshi R; Furuya T; Kaneda H; Hosoda T; Konuma N; Masuko T; Ohashi K; Ikeda T; Koshinaga T; Tomita R; Shinojima Y; Fujiwara K; Watanabe T; Held WA; Nagase H
J Pediatr Surg; 2013 Apr; 48(4):782-8. PubMed ID: 23583134
[TBL] [Abstract][Full Text] [Related]
2. Non-promoter hypermethylation of zygote arrest 1 (ZAR1) in human brain tumors.
Watanabe T; Yachi K; Ohta T; Fukushima T; Yoshino A; Katayama Y; Shinojima Y; Terui T; Nagase H
Brain Tumor Pathol; 2011 Jul; 28(3):199-202. PubMed ID: 21331615
[TBL] [Abstract][Full Text] [Related]
3. Aberrant hypermethylation of non-promoter zygote arrest 1 (ZAR1) in human brain tumors.
Watanabe T; Yachi K; Ohta T; Fukushima T; Yoshino A; Katayama Y; Shinojima Y; Terui T; Nagase H
Neurol Med Chir (Tokyo); 2010; 50(12):1062-9. PubMed ID: 21206179
[TBL] [Abstract][Full Text] [Related]
4. ZAR1 knockdown promotes the differentiation of human neuroblastoma cells by suppression of MYCN expression.
Watanabe Y; Ishizuka Y; Hirano T; Nagasaki-Maeoka E; Hoshi R; Yoshizawa S; Uekusa S; Kawashima H; Sugito K; Shinohara K; Fukuda N; Nagase H; Soma M; Koshinaga T; Fujiwara K
Med Oncol; 2017 Aug; 34(9):158. PubMed ID: 28791558
[TBL] [Abstract][Full Text] [Related]
5. Identification of frequent differentially methylated region in sporadic bladder cancers.
Hasegawa R; Fujiwara K; Obinata D; Kawashima H; Shinojima Y; Igarashi J; Wang X; Ghosh S; Nagase H; Takahashi S
Urol Int; 2015; 94(4):479-84. PubMed ID: 25227574
[TBL] [Abstract][Full Text] [Related]
6. GSTP1 hypermethylation is associated with reduced protein expression, aggressive disease and prognosis in neuroblastoma.
Gumy-Pause F; Pardo B; Khoshbeen-Boudal M; Ansari M; Gayet-Ageron A; Sappino AP; Attiyeh EF; Ozsahin H
Genes Chromosomes Cancer; 2012 Feb; 51(2):174-85. PubMed ID: 22045684
[TBL] [Abstract][Full Text] [Related]
7. Frequent promoter hypermethylation of RASSF1A and CASP8 in neuroblastoma.
Lázcoz P; Muñoz J; Nistal M; Pestaña A; Encío I; Castresana JS
BMC Cancer; 2006 Oct; 6():254. PubMed ID: 17064406
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of promoter DNA methylation in patients with childhood neuroblastoma.
Lau DT; Hesson LB; Norris MD; Marshall GM; Haber M; Ashton LJ
Clin Cancer Res; 2012 Oct; 18(20):5690-700. PubMed ID: 22929802
[TBL] [Abstract][Full Text] [Related]
9. ZAR1 is a novel epigenetically inactivated tumour suppressor in lung cancer.
Richter AM; Kiehl S; Köger N; Breuer J; Stiewe T; Dammann RH
Clin Epigenetics; 2017; 9():60. PubMed ID: 28588743
[TBL] [Abstract][Full Text] [Related]
10. FOXP1 inhibits cell growth and attenuates tumorigenicity of neuroblastoma.
Ackermann S; Kocak H; Hero B; Ehemann V; Kahlert Y; Oberthuer A; Roels F; Theißen J; Odenthal M; Berthold F; Fischer M
BMC Cancer; 2014 Nov; 14():840. PubMed ID: 25406647
[TBL] [Abstract][Full Text] [Related]
11. Detection of CpG island hypermethylation of caspase-8 in neuroblastoma using an oligonucleotide array.
Kamimatsuse A; Matsuura K; Moriya S; Fukuba I; Yamaoka H; Fukuda E; Kamei N; Hiyama K; Sueda T; Hiyama E
Pediatr Blood Cancer; 2009 Jul; 52(7):777-83. PubMed ID: 19260109
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of ZAR1 and SFRP4 methylation status as potentials biomarkers for diagnosis in cervical cancer: exploratory study phase I.
Brebi P; Hoffstetter R; Andana A; Ili CG; Saavedra K; Viscarra T; Retamal J; Sanchez R; Roa JC
Biomarkers; 2014 May; 19(3):181-8. PubMed ID: 24787227
[TBL] [Abstract][Full Text] [Related]
13. Association of epigenetic inactivation of RASSF1A with poor outcome in human neuroblastoma.
Yang Q; Zage P; Kagan D; Tian Y; Seshadri R; Salwen HR; Liu S; Chlenski A; Cohn SL
Clin Cancer Res; 2004 Dec; 10(24):8493-500. PubMed ID: 15623630
[TBL] [Abstract][Full Text] [Related]
14. Zygote arrest 1 gene in pig, cattle and human: evidence of different transcript variants in male and female germ cells.
Uzbekova S; Roy-Sabau M; Dalbiès-Tran R; Perreau C; Papillier P; Mompart F; Thelie A; Pennetier S; Cognie J; Cadoret V; Royere D; Monget P; Mermillod P
Reprod Biol Endocrinol; 2006 Mar; 4():12. PubMed ID: 16551357
[TBL] [Abstract][Full Text] [Related]
15. Expression pattern of the maternal factor zygote arrest 1 (Zar1) in bovine tissues, oocytes, and embryos.
Brevini TA; Cillo F; Colleoni S; Lazzari G; Galli C; Gandolfi F
Mol Reprod Dev; 2004 Dec; 69(4):375-80. PubMed ID: 15457515
[TBL] [Abstract][Full Text] [Related]
16. Aberrant methylation of candidate tumor suppressor genes in neuroblastoma.
Hoebeeck J; Michels E; Pattyn F; Combaret V; Vermeulen J; Yigit N; Hoyoux C; Laureys G; De Paepe A; Speleman F; Vandesompele J
Cancer Lett; 2009 Jan; 273(2):336-46. PubMed ID: 18819746
[TBL] [Abstract][Full Text] [Related]
17. TrkA expression in peripheral neuroblastic tumors: prognostic significance and biological relevance.
Shimada H; Nakagawa A; Peters J; Wang H; Wakamatsu PK; Lukens JN; Matthay KK; Siegel SE; Seeger RC
Cancer; 2004 Oct; 101(8):1873-81. PubMed ID: 15386308
[TBL] [Abstract][Full Text] [Related]
18. Identification of aberrant methylation regions in neuroblastoma by screening of tissue-specific differentially methylated regions.
Sugito K; Kawashima H; Uekusa S; Yoshizawa S; Hoshi R; Furuya T; Kaneda H; Hosoda T; Masuko T; Ohashi K; Ikeda T; Koshinaga T; Fujiwara K; Igarashi J; Ghosh S; Held WA; Nagase H
Pediatr Blood Cancer; 2013 Mar; 60(3):383-9. PubMed ID: 22911660
[TBL] [Abstract][Full Text] [Related]
19. RASSF1A promoter region CpG island hypermethylation in phaeochromocytomas and neuroblastoma tumours.
Astuti D; Agathanggelou A; Honorio S; Dallol A; Martinsson T; Kogner P; Cummins C; Neumann HP; Voutilainen R; Dahia P; Eng C; Maher ER; Latif F
Oncogene; 2001 Nov; 20(51):7573-7. PubMed ID: 11709729
[TBL] [Abstract][Full Text] [Related]
20. Differential expression of neuronal genes defines subtypes of disseminated neuroblastoma with favorable and unfavorable outcome.
Fischer M; Oberthuer A; Brors B; Kahlert Y; Skowron M; Voth H; Warnat P; Ernestus K; Hero B; Berthold F
Clin Cancer Res; 2006 Sep; 12(17):5118-28. PubMed ID: 16951229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
